© 2004 European Society of Cardiology
Diastolic heart failure. Paroxysmal or chronic?
Department of Cardiology, University of Hull, Castle Hill Hospital Kingston upon Hull HU16 5JQ, UK
* Corresponding author. Tel.: +44-1482-624087; fax: +44-1482-624085. E-mail address: pbanerjee{at}ukonline.co.uk
| Abstract |
|---|
|
|
|---|
Heart failure with preserved systolic function is considered by some to be synonymous with diastolic heart failure (DHF). Although recent epidemiological studies have suggested that DHF constitutes 30–50% of all patients with heart failure, many cardiologists dealing with ambulant heart failure patients on a daily basis find that the vast majority of heart failure patients have systolic dysfunction. What could be the reasons for this? Referral bias and varying diagnostic thresholds and interpretation of results could be one important reason. Heart failure with preserved systolic function comprises a heterogeneous group of conditions: whilst some patients may truly have DHF, others may have heart failure due to subtle systolic dysfunction (noted on tissue Doppler imaging of the left ventricular long axis). Other patients actually have pulmonary disease, obesity or ischaemic heart disease, and have their symptoms attributed to diastolic heart failure on the basis of abnormal mitral diastolic flow indices that may, in fact, simply reflect aging. True DHF may be much less prevalent than suggested. A further possibility is that heart failure in patients with diastolic dysfunction might be paroxysmal rather than chronic. This group of patients may present predominantly to acute units like accident and emergency, coronary care units and intensive care units and are, therefore unlikely to figure prominently in the usual outpatient population of chronic systolic left ventricular dysfunction.
Key Words: LV, left ventricular DHF, diastolic heart failure LVH, left ventricular hypertrophy SBP, systolic blood pressure LVEDP, left ventricular end diastolic pressure HFPSF, heart failure with preserved systolic function
Received March 26, 2003; Revised February 16, 2004; Accepted February 23, 2004
| 1. Introduction |
|---|
|
|
|---|
Although epidemiological studies have suggested that 30–50% of heart failure patients have preserved left ventricular (LV) systolic function, the presumption that all of these patients have isolated diastolic heart failure (DHF) is unlikely to be correct [1]. Indeed, it has been argued that patients with preserved LV systolic function and symptoms suggestive of heart failure are frequently misdiagnosed since they often have other reasons for their symptoms such as obesity, pulmonary disease or myocardial ischaemia [2].
The current lack of standardised, reliable and easily applicable diagnostic criteria or a positive, all encompassing definition of DHF [3] is a key factor limiting accurate assessment of the prevalence of this condition. Ongoing trials of DHF [3] will clarify concerns about the outlook of DHF patients with respect to long term mortality [4,5] recurrent hospitalisation [4,5] and cost of care [6].
| 2. Is it really diastolic heart failure? |
|---|
|
|
|---|
Recent studies [7,8] have found that in patients with presumed DHF and left ventricular hypertrophy (LVH), subtle abnormalities of LV systolic function are often present as measured by myocardial tissue Doppler imaging of the left ventricular long axis. Other studies have also reported similar findings [9,10]. This implies that a number of patients labelled as having DHF may not have true DHF; abnormal systolic long axis function is missed on routine 2-dimensional and M-mode echocardiography. The group of patients with clinical heart failure, diastolic dysfunction and mild systolic impairment may be in the middle of a spectrum of heart failure patients, with undetectable or incipient systolic abnormalities and obviously abnormal LV systolic function forming either ends of the spectrum [7].
| 3. Is it heart failure at all? |
|---|
|
|
|---|
Epidemiological studies of DHF (Table 1) have suggested a significant prevalence and an adverse prognosis for the condition. A recently published cross-sectional survey [11] of 2042 randomly selected, 45 years or older residents of Olmstead county, Minnesota has even provided information on the prevalence of preclinical diastolic dysfunction in the community. Rigorous Doppler echocardiographic criteria were applied in this population to assess the prevalence of preclinical diastolic and systolic dysfunction as well as the prevalence of congestive heart failure. Another objective was to determine if diastolic dysfunction is predictive of all cause mortality. 2.2% of the population had clinically validated congestive heart failure (CHF), 44% of whom had preserved LV systolic function (LVEF>50%). Moderate or severe diastolic dysfunction with normal LVEF was present in 5.6% of the population suggesting that preclinical diastolic dysfunction is common. Less than half of those with moderate or severe diastolic dysfunction had recognized CHF. All grades of diastolic dysfunction, which were often not associated with CHF, were associated with a marked increase in all-cause mortality.
|
However, not all studies of DHF have come to the same conclusions. In a small study to assess the prevalence of isolated DHF in the community, MacFayden et al. [12] found that only 18% of the 67 patients referred with shortness of breath by primary care physicians in Arbroath, Scotland had DHF as a cause of their breathlessness. For isolated DHF to be diagnosed as a cause of symptoms, the patients had to have exertional breathlessness, echocardiographic evidence of impaired ventricular filling, weight and age-adjusted impaired exercise tolerance and no other abnormality of respiratory or cardiac function, including no cardiac arrhythmia or electrocardiographic ischaemia on exercise. When strict criteria for diagnosing DHF were applied, the prevalence of DHF was found to be much lower than reported from some epidemiological studies [1].
Caruana et al. [2] in Glasgow, Scotland studied 109 patients referred by general practitioners for suspected heart failure who were subsequently found to have preserved LV systolic function. The aim was to determine whether these patients had other potential causes for their symptoms, rather than being diagnosed with diastolic heart failure. Of these 109, 40 were obese, 54 had obstructive airways disease diagnosed by spirometry and 33 either had a history of angina or myocardial infarction or had undergone a coronary artery bypass graft. Only seven patients lacked a recognized explanation for their symptoms. The study concluded that for most patients with heart failure and preserved systolic function an alternative diagnosis other than DHF is present to explain the symptoms. However, only E/A ratio on mitral inflow Doppler echocardiography was used to establish or exclude diastolic dysfunction in this study.
The paper in the present issue from Wales [13] suggests that there is no difference in left ventricular filling on echocardiography between an appropriate reference population and patients with breathlessness. Many breathless patients, particularly those with a past history of heart disease, are prone to be labelled as having diastolic heart failure, and yet have left ventricular filling indices in the normal range.
| 4. Diastolic heart failure MAY BE acute heart failure |
|---|
|
|
|---|
The experience of many cardiologists dealing with chronic heart failure patients on a daily basis in ambulant outpatients does not tally with the expected high numbers of DHF patients suggested by hospital based epidemiological studies. Since most chronic heart failure patients apparently have LV systolic dysfunction, disbelief is often expressed at the existing data and isolated DHF has become a controversial clinical subject [14]. While one explanation for this discrepancy between observed and expected numbers is that DHF often progresses to systolic heart failure, another possibility is that isolated DHF might present predominantly as acute heart failure which resolves rapidly in response to therapy. It would thus not figure prominently in the population of chronic heart failure patients who are intermittently hospitalised with peripheral fluid overload and who predominantly have systolic heart failure. The natural history of a great number of primary DHF patients may be that of recurrent pulmonary oedema leading to a chronic congestive state only late in the course of the disease.
Of course, acute heart failure with preserved LV systolic function may have causes other than DHF (Table 2). Transient systolic dysfunction and transient mitral regurgitation have been sited as important causes. However, a recent study by Gandhi et al. [15] of 38 hypertensive patients with pulmonary oedema revealed a low prevalence of LV systolic dysfunction and no mitral regurgitation (MR) during the acute episode and on subsequent follow-up, suggesting that exacerbation of diastolic dysfunction and not transient LV systolic dysfunction or acute MR was responsible for heart failure at least in this group of patients.
|
A sudden severe rise in blood pressure (acute pressure overload), over-vigorous intravenous fluid therapy (acute volume overload) or marked tachycardia (mostly atrial fibrillation) can all result in acute heart failure in the presence of normal LV systolic function. This becomes more likely if LV diastolic function is impaired. Marked increase in systolic arterial blood pressure (SBP) causes impairment of diastolic function leading to flash pulmonary oedema [16]. Lowering of the arterial pressure produces a rapid resolution of the pulmonary oedema. Many elderly subjects and patients with LVH or hypertension have Doppler echocardiographic evidence of diastolic dysfunction but no symptoms or signs of heart failure at rest [17–19]. In these patients, rapid increase in SBP above 200 mm of Hg, for any reasons could precipitate pulmonary oedema in the presence of normal LV systolic function [20]. This might happen as a result of poor blood pressure control, underlying renal artery stenosis [21] or a hypertensive response to pain or stress. Pulmonary oedema could also be precipitated by the onset of tachyarrhythmias (especially atrial fibrillation), an increase in preload (e.g. IV fluids post surgery) [22] or vigorous exercise, especially if the exercise is associated with a hypertensive BP response [23–25].
Heart failure associated with preserved systolic function is predominantly a disease of elderly women, most of whom have hypertension [26]. Approximately 60% of patients with heart failure and preserved LV systolic function have hypertension [27]. Hypertensive heart failure manifests initially as recurrent pulmonary oedema and later in the course of the disease as congestive heart failure. DHF in hypertensives is therefore more acute than chronic heart failure.
Ageing affects diastolic function more than systolic [28]. Ageing and hypertension are characterized by increased deposition of interstitial and perivascular collagen in the myocardium resulting in fibrosis [16,17]. Both conditions also cause LVH [16,17]. Ventricular fibrosis (which occurs as a form of structural remodelling) and LVH result in decreased compliance and increased LV filling pressure. Fibrosis also causes reduced coronary reserve resulting in myocardial ischaemia and reparative fibrosis that in turn leads to progression of diastolic dysfunction towards overt heart failure [29]. Initially, the atrial contribution to late diastolic filling compensates for the decrease in early diastolic filling, maintaining stroke volume at the expense of increased end diastolic pressure. With time, this leads to left atrial enlargement and atrial fibrillation (AF), which is a precipitating factor for the development of acute heart failure [30].
Thus hypertension and old age, when they exist together, make an individual prone to developing DHF. Isolated systolic hypertension is a well-known association of old age. Diabetes mellitus and coronary artery disease often coexist in the elderly hypertensive and are also causes of diastolic dysfunction [30,31]. Pulmonary oedema occurring in DHF may be the result of complex interaction of conditions that synergistically exacerbate diastolic dysfunction. The fact that preclinical diastolic dysfunction is common would make this interaction more likely.
Imagine a patient with acute DHF. A common scenario is an elderly lady with hypertension and diabetes who is admitted with acute coronary syndrome that causes minor myocardial damage. Soon after admission she goes into atrial fibrillation and then develops acute pulmonary oedema. Echocardiography done during pulmonary oedema shows concentric LVH with preserved LV systolic function and abnormal diastolic variables. This lady already had preclinical LV diastolic impairment related to hypertension, diabetes and advanced age. Global acute ischaemia may have resulted in further stiffening of the ventricle and worsening of diastolic dysfunction, causing increased left ventricular end-diastolic pressure. A hypertensive response to ischaemia increased afterload and worsened diastolic function. Finally, tachycardia related to atrial fibrillation reduced LV filling time and precipitated pulmonary oedema by further increasing LVEDP. Loss of atrial contribution to ventricular filling may have also caused symptoms. Treatment of pulmonary oedema with intravenous nitrates also treats the acute ischaemia, responsible for the elevated LVEDP and rate control of AF increases the LV filling time resulting in rapid resolution of the pulmonary oedema. Outside acute episodes, such patients are unlikely to have persistent symptoms, and are unlikely to present with the chronic heart failure syndrome in an outpatients setting.
| 5. Conclusions |
|---|
|
|
|---|
It is likely that heart failure with preserved systolic function includes a pathophysiologically heterogeneous group of conditions and some misdiagnosis. Each problem may require a different therapeutic approach. How many falls into which category remains unknown. Large randomised controlled trials with unfocussed entry criteria may not be the most effective approach to finding useful treatments.
| References |
|---|
|
|
|---|
- Grossman W. Defining diastolic dysfunction. Circulation (2000) 101:2020–2021.
[Free Full Text] - Caruana L., Petrie M.C., Davie A.P., McMurray J.J.V. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from diastolic heart failure'or from misdiagnosis? A prospective descriptive study. BMJ (2000) 321:215–218.
[Abstract/Free Full Text] - Banerjee P., Banerjee T., Khand A., Clark A.L., Cleland J.G.F. Diastolic heart Failure. Neglected or misdiagnosed? J Am Coll Cardiol (2002) 39:138–141.
[Abstract/Free Full Text] - Pernenkil R., Vinson J.M., Shah A.S., et al. Course and prognosis in patients >70 years of age with congestive heart failure and normal vs. abnormal left ventricular ejection fraction. Am J Cardiol (1997) 79:216–219.[CrossRef][Web of Science][Medline]
- Philbin E.F., Rocco T.A., Lindenmuth N.W., Ulrich K., Jenkins P.L. Systolic vs. diastolic heart failure in community practice: clinical features, outcomes and the use of angiotensin—converting enzyme inhibitors. Am J Med (2000) 109:605–613.[CrossRef][Web of Science][Medline]
- Vasan R.S., Levy D. Defining diastolic heart failure. A call for standardized diagnostic criteria. Circulation (2000) 101:2118–2121.
[Free Full Text] - Yip G., Wang M., Zhang Y., Fung J.W., Ho P.Y., Sanderson J.E. Left ventricular long axis function in diastolic heart failure is reduced in both systole and diastole: time for a redefinition? Heart (2002) 87:121–125.
[Abstract/Free Full Text] - Nikitin N.P., Witte K.K.A., Clark A.L., Cleland J.G.F. Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function. Am J Cardiol (2002) 90(10):1174–1177.[CrossRef][Web of Science][Medline]
- Vinereanu D., Florescu N., Sculthorpe N., Tweddel A.C., Stephens M.R., Fraser A.G. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol (2001) 88:53–58.[CrossRef][Web of Science][Medline]
- Bolognesi R., de Simone G., Devereux R.B., Roman M.J., et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol (1994) 23:1444–1451.[Abstract]
- Redfield M.M., Jacobsen S., Burnett J., et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. J Am Med Assoc (2003) 289:194–202.
[Abstract/Free Full Text] - MacFayden R.J., MacLeod C.M., Shiels P., Smith W.R., MacDonald T.M. Isolated diastolic heart failure as a cause of breathlessness in the community: the Arbroath study. Eur J Heart Fail (2001) 3:243–248.
[Abstract/Free Full Text] - Sim MF, Ho SF, O'Mahony MS, Steward JA, Buchalter M, Burr M. European reference values for Doppler indices of left ventricular diastolic filling. Eur J Heart Fail 2004: in this issue.
- How to diagnose diastolic heart failure. European Study group on diastolic heart failure. Eur Heart J 1998; 19: pp. 990–1003.
- Gandhi S.K., Powers J.C., Nomeir A., Fowle K., Kitzman D.W., Rankin K.M., et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med (2001) 344:17–22.
[Abstract/Free Full Text] - Zampaglione B., Pascale C., Marchisio M., Cavallo-Perin P. Hypertensive urgencies and emergencies: prevalence and clinical presentation. Hypertension (1996) 27:144–147.
[Abstract/Free Full Text] - Little W.C., Downes T.R. Clinical evaluation of left ventricular diastolic performance. Prog Cardiovas Dis (1990) 32:273–290.[CrossRef][Web of Science][Medline]
- Little W.C., Warner J.G. Jr, Rankin K.M., et al. Evaluation of left ventricular diastolic function from the pattern of left ventricular filling. Clin Cardiol (1998) 21:5–9.[Web of Science][Medline]
- Nishimura R.A., Tajik A.J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta stone. J Am Coll Cardiol (1997) 30:8–18.[Abstract]
- Warner J.G. Jr, Metzger D.C., Kitzman D.W. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol (1999) 33:1567–1572.
[Abstract/Free Full Text] - Diamond J.R. Flash pulmonary edema and the diagnostic suspicion of occult renal artery stenosis. Am J Kidney Dis (1993) 21:328–330.[Web of Science][Medline]
- Vasan R.S., Benjamin E.J., Levy D. Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure. Arch Intern Med (1996) 156:146–157.
[Abstract/Free Full Text] - Stratton J.R., Levy W.C., Cerqueira M.D., et al. Cardiovascular responses to exercise: effects of aging and exercise training in healthy men. Circulation (1994) 89:1648–1665.
[Abstract/Free Full Text] - Fleg J.L., O'Connor F., Gerstenblith G., et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol (1995) 78:1648–1655.
- Fagard R., Staessen J., Thijs L., Amery A. Prognostic significance of exercise vs. resting blood pressure in hypertensive men. Hypertension (1991) 17:574–578.
[Abstract/Free Full Text] - Davie A.P., Francis C.M., Caruanha L., Sutherland G.R., McMurray J.J. The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure. Eur Heart J (1997) 18:981–984.
[Abstract/Free Full Text] - Bonow R.O., Udelson J.E. Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management. Ann Intern Med (1992) 117:502–510.
[Abstract/Free Full Text] - Wei J.Y. Age and the cardiovascular system. N Engl J Med (1992) 327:1735–1739.[Web of Science][Medline]
- Javier D., Lopez B., Gonzalez A., Querezeta R. Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol (2001) 16:328–335.[CrossRef][Web of Science][Medline]
- Mandinov L., Eberli F.R., Sieler C., Hess O.M. Diastolic heart failure. Cardiovascular research (2000) 45:813–825.
- Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part 2: Causal mechanisms and treatment. Circulation (2002) 105:1503–1508.
[Free Full Text] - McAlister F.A., Teo K.K., Taher M., et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J (1999) 138:87–94.[CrossRef][Web of Science][Medline]
- Vasan R.S., Larson M.G., Benjamin E.J., et al. Congestive heart failure in subjects with normal vs. reduced left ventricular ejection fraction. Prevalence and mortality in a population based cohort. J Am Coll Cardiol (1999) 33:1948–1955.
[Abstract/Free Full Text] - Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community: a study of all incident cases in Olmstead county, Minnesota in 1991. Circulation (1998) 98:2282–2289.
[Abstract/Free Full Text] - Philbin E.F., Rocco T.A., Lindenmuth N.W., Ulrich K., Jenkins P.L. Systolic vs. diastolic heart failure in community practice: clinical features, outcomes and the use of angiotensin—converting enzyme inhibitors. Am J Med (2000) 109:605–613.[CrossRef][Web of Science][Medline]
- Cowie M.R., Wood D.A., Coates A.J.S., et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart (2000) 83:505–510.
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
G. W. De Keulenaer and D. L. Brutsaert Systolic and diastolic heart failure: Different phenotypes of the same disease? Eur J Heart Fail, February 1, 2007; 9(2): 136 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Milo-Cotter, K. F. Adams, C. M. O'Connor, N. Uriel, E. Kaluski, G. M. Felker, B. Weatherley, Z. Vered, and G. Cotter Acute heart failure associated with high admission blood pressure -- A distinct vascular disorder? Eur J Heart Fail, February 1, 2007; 9(2): 178 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Sanderson Heart failure with a normal ejection fraction Heart, February 1, 2007; 93(2): 155 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G.F. Cleland, M. Tendera, J. Adamus, N. Freemantle, L. Polonski, J. Taylor, and on behalf of PEP-CHF Investigators The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur. Heart J., October 1, 2006; 27(19): 2338 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghio Role of echo Doppler techniques in the evaluation and treatment of heart failure patients Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E28 - E31. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghio, G. Magrini, A. Serio, C. Klersy, A. Fucilli, A. Ronaszeki, P. Karpati, G. Mordenti, A. Capriati, P. A. Poole-Wilson, et al. Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy Eur. Heart J., March 1, 2006; 27(5): 562 - 568. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



